PROCEPT BioRobotics (PRCT) Total Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Total Liabilities for 7 consecutive years, with $139.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Liabilities rose 9.45% year-over-year to $139.3 million in Q2 2026; TTM through Jun 2026 was $139.3 million, a 9.45% increase from a year earlier, with the FY2025 full-year figure at $142.2 million, up 7.9% from the prior year.
• Total Liabilities was $139.3 million for Q2 2026 at PROCEPT BioRobotics, roughly flat from $139.4 million in the prior quarter.
• Over five years, Total Liabilities peaked at $142.2 million in Q4 2025 and troughed at $68.2 million in Q1 2022.
• A 5-year average of $119.2 million and a median of $123.3 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities sank 65.23% in 2022 and surged 63.33% in 2023, its largest moves.
• Over 5 years, Total Liabilities stood at $112.3 million in 2022, then gained by 10.43% to $124.0 million in 2023, then advanced by 6.32% to $131.8 million in 2024, then increased by 7.9% to $142.2 million in 2025, then declined by 2.06% to $139.3 million in 2026.
• The last three Total Liabilities figures came in at $139.3 million (Q2 2026), $139.4 million (Q1 2026), and $142.2 million (Q4 2025), per Business Quant data.